Diastereoselective synthesis of 3,4-dihydro-2H-pyran-4-carboxamides through an unusual regiospecific quasi-hydrolysis of a cyano group

  1. 1 ,
  2. 1 ,
  3. 1 ,
  4. 1 ,
  5. 2 and
  6. 1
1Department of Organic and Pharmaceutical Chemistry, Ulyanov Chuvash State University, Moskovskiy av. 15, Cheboksary, Russia
2Department of General Chemistry, Lomonosov Moscow State University, Leninskie gory 1, Moscow, Russia
  1. Corresponding author email
Associate Editor: T. J. J. Müller
Beilstein J. Org. Chem. 2016, 12, 2093–2098. https://doi.org/10.3762/bjoc.12.198
Received 18 Jun 2016, Accepted 15 Sep 2016, Published 27 Sep 2016
Full Research Paper
cc by logo

Abstract

An efficient diastereoselective approach for the synthesis of functionalized 3,4-dihydro-2H-pyran-4-carboxamides with variable frame was developed based on the reaction of available 4-oxoalkane-1,1,2,2-tetracarbonitriles (adducts of TCNE and ketones) with aldehydes in an acidic media. An unusual process of quasi hydrolysis of the cyano group was observed in the course of the described regio- and diastereoselective transformation.

Introduction

Dihydro- and tetrahydropyran moieties are very important structural fragments in organic synthesis. They are part of many natural compounds, biologically active substances and drugs [1-4]. For instance, Zanamivir and Laninamivir which are recommended for the treatment and prophylaxis of influenza caused by influenza A and B viruses contain a 3,4-dihydro-2H-pyran fragment [5]. Moreover, dihydropyrans have been proven to be particularly useful in the preparation of cyclic components of macrocyclic antibiotics [6,7] and as precursors in the synthesis of C-glycosides [8].

Modern and convenient methods for the construction of 3,4-dihydro-2H-pyrans are based on the interaction between ylidene derivatives of methylene-active compounds and β-oxo derivatives of acids or ketones [9-11], and also on the reactions of phenols with carbonyl compounds [12]. An interesting example that had been recently described is the involvement of diazolactones in an inverse electron-demand Diels–Alder reaction [13]. At the same time the synthesis of 3,4-dihydro-2H-pyrans with a carboxamide group is a not sufficiently explored area. There is only one way to produce 3,4-dihydro-2H-pyran-4-carboxamides from substrates containing no pyran ring described in the literature (Scheme 1) [14].

[1860-5397-12-198-i1]

Scheme 1: An exclusive approach to 3,4-dihydro-2H-pyran-4-carboxamides from non-pyran sources.

In view of a directed synthesis of inaccessible heterocyclic molecules, 4-oxoalkane-1,1,2,2-tetracarbonitriles 1 are very promising substrates. They can be easily prepared from an appropriate ketone and TCNE (Scheme 2). Previously we reported about several ways of heterocyclization thereof [15-23], including the formation of pyran derivatives [20-24].

[1860-5397-12-198-i2]

Scheme 2: Known approach to pyran derivatives based on ketonitriles 1.

Our recent work should be noted individually, we were able to prepare various functionalized pyrano[3,4-c]pyrrole derivatives via diastereoselective cascade reaction [23]. The crucial stage of the described transformation is the formation of a pyran-4-carboxamide intermediate. A trace amount of it was isolated accidentally and we could not repeat this procedure and characterize the compound by spectra.

Results and Discussion

In continuation of our interest in this area, we focused our attention on the extention of the existing methods for the synthesis of a series of pyran heterocycles. Therefore, we have studied more thoroughly the transformation of ketonitriles 1 in acidic media in the presences of aldehydes. We had found that 3,3,4-tricyano-3,4-dihydro-2H-pyran-4-carboxamides 2 nevertheless could be obtained in good yields (57–69%) by the action of hydrochloric acid. A prominent feature of the reaction that has been developed is the possibility to vary substituents at the 2-, 5- and 6-positions of the pyran cycle, using alkyl and aryl moieties to design the rare pyran-4-carboxamide molecules. Moreover, during the regio- and diastereoselective transformation a quasi-hydrolysis of only one of the cyano groups had occurred. As a result only one diastereomer of 3,4-dihydro-2H-pyran-4-carboxamides 2 was obtained (Table 1).

Table 1: Synthesis of 3,3,4-tricyano-3,4-dihydro-2H-pyran-4-carboxamides 2.

[Graphic 1]
Entry Ketonitrile Aldehyde Product Yield (%)
1 [Graphic 2]
1a
[Graphic 3] [Graphic 4]
2a
57
2 [Graphic 5]
1b
[Graphic 6] [Graphic 7]
2b
59
3 [Graphic 8]
1c
[Graphic 9] [Graphic 10]
2c
64
4 [Graphic 11]
1d
[Graphic 12] [Graphic 13]
2d
61
5 [Graphic 14]
1e
[Graphic 15] [Graphic 16]
2e
66
6 [Graphic 17]
1e
[Graphic 18] [Graphic 19]
2f
64
7 [Graphic 20]
1e
[Graphic 21] [Graphic 22]
2g
61
8 [Graphic 23]
1e
[Graphic 24] [Graphic 25]
2h
69
9 [Graphic 26]
1e
[Graphic 27] [Graphic 28]
2i
67
10 [Graphic 29]
1f
[Graphic 30] [Graphic 31]
2j
59

The structure of pyrans 2 as well as the trans configuration of the substituents at the asymmetric atoms C2 and C4 were established by X-ray diffraction (Figure 1) [25]. The conformation of the six-membered heterocyclic ring is stabilized by an intermolecular hydrogen bond C2–H2···O2. The distance O2···H2 is 2.31 Å. In the crystal, the molecules form centrosymmetric dimers through hydrogen bonding N1–H11···O2 (H1···O2 1.98 Å, angle N1–H1···O2 176°). Structures of compounds 2 are also consistent with IR, 1H NMR spectroscopy and mass spectrometry. The IR spectra characterized with the absorption bands of non-conjugated C≡N in the area of 2240–2260 cm−1 and two intensive bands of amide N–H bonds in the area of 3150–3450 cm−1. The 1H NMR spectra of compounds 2 are characterized with two individual downfield signals of amide protons in the area of 8–9 ppm, signals of the OCH fragment in the area of 4.9–6.5 ppm, depending on the substituent R3, and the signals of other appropriate alkyl and aryl substituents.

[1860-5397-12-198-1]

Figure 1: The molecular structure of 2a with atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms are drawn as small spheres of arbitrary radii.

There are two cascade mechanisms that could be proposed for the 3,4-dihydro-2H-pyran-4-carboxamides 2 formation (Scheme 3).

[1860-5397-12-198-i3]

Scheme 3: Plausible reaction pathways for 3,4-dihydro-2H-pyran-4-carbxamides 2 formation.

Both mechanisms apparently start from the interaction of ketonitrile 1 with aldehyde under subsequent formation of the intermediate 2,7-dioxabicyclo[3.2.1]octane derivative 3. This reaction was separately described by us previously and it is the crucial reason for the diastereoselectivity of the whole transformation [21,22]. Further acid-catalyzed addition of water to the imino group (B) is probably accompanied with decyclization (C) and dehydratation processes forming compound 2 (Scheme 3, path I). However, according to the literature, in most cases, the addition of water to the similar cyclic iminoethers leads to hydrolysis and formation of lactones [26,27]. Another probable pathway involves the protonation of the imino group nitrogen atom to form an iminium salt (D) and subsequent decyclization of iminolactone ring (E) without participation of water (Scheme 3, path II).

To establish the actual mechanism and to prove the intermediate formation of bicyclo[3.2.1]octane derivatives 3 we carried out the reaction of specially prepared 6-imino-2,7-dioxabicyclo[3.2.1]octane-3,3,4-tricarbonitrile 3h [21] with dry trifluoroacetic acid under anhydrous conditions (Table 2, entry 6). The successful implementation of this process and isolation of product 2h with good yield indicate the path of transformations without the participation of water (Scheme 3, path II) as actual.

Table 2: Acid-catalysts screeninga.

[Graphic 32]
Entry Acid Co-solvent Conditions Time (min) Yield after 2 hb (%)
1 HCl (aq 15%) iPrOH 80 °C 5 71
2 HBr (aq 40%) iPrOH 80 °C 3 65
3 HNO3 (aq 50%) 80 °C 3 67
4 H2SO4 (aq 50%) 1,4-dioxane rt 15 c
5 CH3COOH (dry) 110 °C 5 d
6 CF3COOH (dry) rt 10 69

aReaction conditions: 3h (0.5 mmol), acid (0.75 mL), solvent (0.75 mL, if marked); bIsolated yield; cThe reaction does not stop at the amide formation, further transformations proceeds. dThe results were published previously [23].

Such an abnormal resistance of the imine moiety to be simply hydrolyzed in aqueous acidic media is very exciting. Therefore we attempted to use other acids to investigate the behavior of the imine moiety in presence thereof, but all acids promote only the iminolactone decyclization process without traces of lactone derivative 4 (Table 2).

It is also important to note that during the reaction pathway (Scheme 3) a carbonyl-assisted carbonitrile hydration effect (CACHE) was occured. The carbonyl group, through the formation of hemiketal (A), became a source of a hydroxy group that cyclized regiospecifically to the spatially proximate cyano group and caused the carboxamide formation. CACHE processes are essential for the chemistry of oxonitriles and sometimes can be the reason for unusual quasi-hydrolysis of the cyano group under mild conditions [15,19,23], but it was not mentioned by many authors [28-31].

Conclusion

In conclusion, we have developed a new efficient approach to a rare group of heterocycles, namely, functionalized 3,4-dihydro-2H-pyran-4-carboxamides with variable frame and exceptional diastereoselectivity based on the reaction of available 4-oxoalkane-1,1,2,2-tetracarbonitriles (adducts of TCNE and ketones) with aldehydes in acidic media. Unusual processes of regiospecific quasi-hydrolysis of a cyano group and abnormal resistance of the imine moiety to be hydrolyzed in aqueous acidic media were observed in the course of the described transformation. Moreover, the intermediate 6-imino-2,7-dioxabicyclo[3.2.1]octane-4,4,5-tricarbonitriles 3 had demonstrated a cytotoxic activity in various cancer cell lines [32], therefore the derived 3,4-dihydro-2H-pyrans 2 are very promising for biological studies.

Supporting Information

Supporting Information File 1: Experimental data and characterization of all new compounds.
Format: PDF Size: 798.5 KB Download

Acknowledgements

This work was supported by a stipend of the President of the Russian Federation for young scientists and graduate students (SP-127.2016.4). The XRD study was carried out using the equipment purchased from the funds of the program of development of the Moscow University and within the framework of the agreement on collaboration between the Chemical Department of the Lomonosov Moscow State University and the Chemical-Pharmaceutical Department of the I.N. Ulyanov Chuvash State University

References

  1. Marco, J. A.; Carda, M.; Murga, J.; Falomir, E. Tetrahedron 2007, 63, 2929–2958. doi:10.1016/j.tet.2006.12.047
    Return to citation in text: [1]
  2. Elliott, M. C. J. Chem. Soc., Perkin Trans. 1 2002, 2301–2323. doi:10.1039/B201515N
    Return to citation in text: [1]
  3. Lin, C.-H.; Chang, T.-C.; Das, A.; Fang, M.-Y.; Hung, H.-C.; Hsu, K.-C.; Yang, J.-M.; von Itzstein, M.; Mong, K. K. T.; Hsu, T.-A.; Lin, C.-C. Org. Biomol. Chem. 2013, 11, 3943–3948. doi:10.1039/C3OB40624E
    Return to citation in text: [1]
  4. Koester, D. C.; Werz, D. B. Beilstein J. Org. Chem. 2012, 8, 675–682. doi:10.3762/bjoc.8.75
    Return to citation in text: [1]
  5. von Itzstein, M.; Wu, W.-Y.; Kok, G. B.; Pegg, M. S.; Dyason, J. C.; Jin, B.; Phan, T. V.; Smythe, M. L.; White, H. F.; Oliver, S. W.; Colman, P. M.; Varghese, J. N.; Ryan, D. M.; Woods, J. M.; Bethell, R. C.; Hotham, V. J.; Cameron, J. M.; Penn, C. R. Nature 1993, 363, 418–423. doi:10.1038/363418a0
    Return to citation in text: [1]
  6. Paterson, I.; Cumming, J. G.; Ward, R. A.; Lamboley, S. Tetrahedron 1995, 51, 9393–9412. doi:10.1016/0040-4020(95)00546-K
    Return to citation in text: [1]
  7. Paterson, I.; Smith, J. D.; Ward, R. A. Tetrahedron 1995, 51, 9413–9436. doi:10.1016/0040-4020(95)00547-L
    Return to citation in text: [1]
  8. Parker, K. A.; Coburn, C. A.; Koh, Y.-h. J. Org. Chem. 1995, 60, 2938–2941. doi:10.1021/jo00114a057
    Return to citation in text: [1]
  9. Gajulapalli, V. P. R.; Lokesh, K.; Vishwanath, M.; Kesavan, V. RSC Adv. 2016, 6, 12180–12184. doi:10.1039/C5RA25025K
    Return to citation in text: [1]
  10. Biswas, S.; Dagar, A.; Mobin, S. M.; Samanta, S. Org. Biomol. Chem. 2016, 14, 1940–1945. doi:10.1039/C5OB02400E
    Return to citation in text: [1]
  11. Ta, L.; Axelsson, A.; Sundén, H. Green Chem. 2016, 18, 686–690. doi:10.1039/C5GC01965F
    Return to citation in text: [1]
  12. Shirini, F.; Abedini, M.; Seddighi, M.; Jolodar, O. G.; Safarpoor, M.; Langroodi, N.; Zamani, S. RSC Adv. 2014, 4, 63526–63532. doi:10.1039/C4RA12361A
    Return to citation in text: [1]
  13. Diac, A. P.; Ţepeş, A.-M.; Soran, A.; Grosu, I.; Terec, A.; Roncali, J.; Bogdan, E. Beilstein J. Org. Chem. 2016, 12, 825–834. doi:10.3762/bjoc.12.81
    Return to citation in text: [1]
  14. Maruoka, H.; Okabe, F.; Yamagata, K. Heterocycles 2007, 74, 383–396. doi:10.3987/COM-07-S(W)16
    Return to citation in text: [1]
  15. Ershov, O. V.; Fedoseev, S. V.; Belikov, M. Yu.; Ievlev, M. Yu. RSC Adv. 2015, 5, 34191–34198. doi:10.1039/c5ra01642h
    Return to citation in text: [1] [2]
  16. Belikov, M. Yu.; Fedoseev, S. V.; Ievlev, M. Yu.; Ershov, O. V.; Tafeenko, V. A. RSC Adv. 2015, 5, 65316–65320. doi:10.1039/c5ra11304k
    Return to citation in text: [1]
  17. Belikov, M. Yu.; Ievlev, M. Yu.; Belikova, I. V.; Ershov, O. V.; Tafeenko, V. A.; Surazhskaya, M. D. Chem. Heterocycl. Compd. 2015, 51, 518–525. doi:10.1007/s10593-015-1731-4
    Return to citation in text: [1]
  18. Ershov, O. V.; Maksimova, V. N.; Lipin, K. V.; Belikov, M. Yu.; Ievlev, M. Yu.; Tafeenko, V. A.; Nasakin, O. E. Tetrahedron 2015, 71, 7445–7450. doi:10.1016/j.tet.2015.06.031
    Return to citation in text: [1]
  19. Fedoseev, S. V.; Ershov, O. V.; Belikov, M. Yu.; Lipin, K. V.; Bardasov, I. N.; Nasakin, O. E.; Tafeenko, V. A. Tetrahedron Lett. 2013, 54, 2143–2145. doi:10.1016/j.tetlet.2013.02.043
    Return to citation in text: [1] [2]
  20. Sheverdov, V. P.; Ershov, O. V.; Nasakin, O. E.; Chernushkin, A. N.; Tafeenko, V. A. Russ. J. Org. Chem. 2002, 38, 1001–1004. doi:10.1023/A:1020801612443
    Return to citation in text: [1] [2]
  21. Ershov, O. V.; Ievlev, M. Yu.; Tafeenko, V. A.; Nasakin, O. E. Green Chem. 2015, 17, 4234–4238. doi:10.1039/c5gc00909j
    Return to citation in text: [1] [2] [3] [4]
  22. Ievlev, M. Yu.; Ershov, O. V.; Milovidova, A. G.; Belikov, M. Yu.; Nasakin, O. E. Chem. Heterocycl. Compd. 2015, 51, 457–461. doi:10.1007/s10593-015-1720-7
    Return to citation in text: [1] [2] [3]
  23. Ievlev, M. Yu.; Ershov, O. V.; Tafeenko, V. A. Org. Lett. 2016, 18, 1940–1943. doi:10.1021/acs.orglett.6b00867
    Return to citation in text: [1] [2] [3] [4] [5]
  24. Rappoport, Z.; Ladkani, D. J. Chem. Soc., Perkin Trans. 1 1974, 2595–2601. doi:10.1039/P19740002595
    Return to citation in text: [1]
  25. The crystallographic data for this molecule can be obtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif. The CCDC number is 1469776.
    Return to citation in text: [1]
  26. Belikov, M. Yu.; Ershov, O. V.; Lipovskaya, I. V.; Fedoseev, S. V.; Lipin, K. V.; Nasakin, O. E. Russ. J. Org. Chem. 2013, 49, 1195–1198. doi:10.1134/S1070428013080162
    Return to citation in text: [1]
  27. Vasil’ev, A. N.; Lyshchikov, A. N.; Nasakin, O. E.; Kayukov, Ya. S.; Tafeenko, V. A. Russ. J. Org. Chem. 2005, 41, 279–282. doi:10.1007/s11178-005-0157-3
    Return to citation in text: [1]
  28. Shen, X.-L.; Zhao, R.-R.; Mo, M.-J.; Peng, F.-Z.; Zhang, H.-B.; Shao, Z.-H. J. Org. Chem. 2014, 79, 2473–2480. doi:10.1021/jo402741g
    Return to citation in text: [1]
  29. Gartshore, C. J.; Lupton, D. W. Angew. Chem., Int. Ed. 2013, 52, 4113–4116. doi:10.1002/anie.201209069
    Return to citation in text: [1]
  30. Ergün, Y.; Okay, G.; Patir, S. J. Heterocycl. Chem. 2002, 39, 315–317. doi:10.1002/jhet.5570390212
    Return to citation in text: [1]
  31. Kayukov, Ya. S.; Bardasov, I. N.; Ershov, O. V.; Nasakin, O. E.; Kayukova, O. V.; Tafeenko, V. A. Russ. J. Org. Chem. 2012, 48, 485–490. doi:10.1134/s1070428012040033
    Return to citation in text: [1]
  32. Nasakin, O. E.; Lyshchikov, A. N.; Kayukov, Ya. S.; Sheverdov, V. P. Pharm. Chem. J. 2000, 34, 170–185. doi:10.1007/BF02524593
    Return to citation in text: [1]
Other Beilstein-Institut Open Science Activities